Miles Parkes
0000-0002-6467-0631
Publication & Citation Trends
Publications
0 total
CO25 Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource
Cited by 0
Semantic Scholar
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial. OA
Cited by 5
Semantic Scholar
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research
Cited by 1
Semantic Scholar
O5 BOUGIECAP DILATATION DEVICE: NOVEL ENDOSCOPIC METHOD FOR TREATMENT OF OESOPHAGEAL STRICTURES-RESULTS FROM A MULTICENTRE STUDY
Cited by 0
Semantic Scholar
OWE-02 The IBD BioResource: Progressing from genetics to function and clinical translation in CD & UC OA
Cited by 0
Semantic Scholar
Exploring the genetic architecture of inflammatory bowel disease 1 by whole genome sequencing identifies association at ADCY7 2
Cited by 0
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(230)
Microscopic Colitis
(102)
Helicobacter pylori-related gastroenterology studies
(56)
Immunodeficiency and Autoimmune Disorders
(39)
Eosinophilic Esophagitis
(30)
Affiliations
National Health Service
Translational Research Institute
Centre for Human Genetics
University of Helsinki
University College London Hospitals NHS Foundation Trust